How AI and Advanced Analytics can Support Process Excellence and Compliance Within Pharma Manufacturing

Published on: 


Webinar Date/Time: Tue, Dec 13, 2022 9:00 AM EST

Pharmaceutical manufacturers are facing decreasing margins and need to identify new ways to increase yield, quality and efficiency through increased visibility into their operations and better understand their processes. Join this webinar to learn how advanced technologies enable manufacturers to continuously determine, in real time, actionable insights and act quickly on them in order to meet current and future market demands

Register free:

Event Overview:
Pharmaceutical manufacturers are under increasing pressure to fast-track technological innovation to improve their manufacturing operations. In order to adapt to new approaches like ‘Industry 4.0’ and continuous manufacturing, combat growing and intense competition, and keep up with the increasing demand for personalized medicine and therapies, organizations are seeking to identify areas where technology can make the most impact.
In this webinar, attendees will hear from three experts on the following topics:

  • Benefits of Pharma 4.0 and Enabling Technologies like AI and ML
  • Practical use cases in achieving compliance using AI in Pharma manufacturing
  • Real world reflections on Manufacturing Intelligence

Key Learning Objectives:

  • How advanced technologies, such as artificial intelligence and machine learning, will deliver the ability to seamlessly and efficiently capture and monitor disparate data from across the organization.
  • Initial steps to reaching operational intelligence in a GxP compliant manner with end-to-end data integrity
  • How adopting these technologies results in pertinent benefits, such as decreased downtime and increased productivity

Who Should Attend:

  • Site leads/head of site, compliance, quality, digital transformation, technology, operations


Elvis Graffeo
LifeBee partner and Director for the Industrial Operations area
Digitalizing Life Sciences

Elvis Graffeo is a LifeBee partner and Director for the Industrial Operations area. Graduated in Computer Engineering at Politecnico di Milano in 1994. He has over 25 years of experience in Consulting and in the management and implementation of System Integration software projects and Consulting for Production, Maintenance, Quality in the "regulated" Life Science field. He started his career in 1996 in Atos Origin as a Consultant in the Life Science sector within the Health Care Unit working with leading Italian and international pharmaceutical companies.
In 2004 he was among the founders of LifeBee, Italian consulting firm which has now 75+ clients and 1000+ projects in Life Science.
Since 2016 Graffeo led the Serialization anc Track&Trace Business Unit for the company reaching over 30+ clients and 100+ projects in this field.

Pep Gubau
CEO, CTO, Co-Founder

Pep GubauCEO, CTO, Co-FounderAizon
Pep Gubau is the CEO, CTO, and founder of Aizon and has been a tech entrepreneur for the last 30 years. Since Aizon's inception in 2013, Pep has been responsible for the company’s product vision and technology strategy, shaping the company’s mission of transforming the Pharma and Biotech Manufacturing Industry using Aizon’s innovative technologies.

Pep is an economist with an engineering background and holds several international patents related to the encryption, transmission, storage and processing of data for regulated environments in the cloud. Pep loves detecting opportunities, understanding challenges, imagining and building solutions, envisioning the future, and creating and growing Tech companies from scratch.

Michele D’Alessandro
Strategic Advisory Board member
Aizon; VP and CIO of Manufacturing IT
Merck (retired)

An Information Technology professional for more than 30 years, Michele C. D’Alessandro is most recently Vice President and CIO of Manufacturing IT at Merck. In this role, she provided strategic leadership, oversight and delivery of information technology and digital solutions for the Merck Manufacturing Division. A change agent with proven track-record of delivering high-impact projects producing outstanding business results broadly across Pharmaceutical Supply Chain and Manufacturing, Michele and her team have been nationally recognized for the past 7 years in the areas of technical innovation, including next generation data and analytics platforms; supply chain transformation; and resiliency /modernization/digitization in manufacturing plants. In Nov 2017, Michele was awarded a Gold Stevie® Award for Women in Business in the Life Sciences and Healthcare Transformation category. Michele was named to Bold’s Business Top 20 of Chief Information Officers for 2019. She currently runs her own consultancy business, providing advisory services with an emphasis on IT Transformation and Women in STEM.

Register free: